238 related articles for article (PubMed ID: 31374811)
1. Arsenic-Induced Carcinogenesis and Immune Dysregulation.
Huang HW; Lee CH; Yu HS
Int J Environ Res Public Health; 2019 Aug; 16(15):. PubMed ID: 31374811
[TBL] [Abstract][Full Text] [Related]
2. Immunological dysfunction in chronic arsenic exposure: From subclinical condition to skin cancer.
Yu S; Liao WT; Lee CH; Chai CY; Yu CL; Yu HS
J Dermatol; 2018 Nov; 45(11):1271-1277. PubMed ID: 30144155
[TBL] [Abstract][Full Text] [Related]
3. Role of mitochondria, ROS, and DNA damage in arsenic induced carcinogenesis.
Lee CH; Yu HS
Front Biosci (Schol Ed); 2016 Jun; 8(2):312-20. PubMed ID: 27100709
[TBL] [Abstract][Full Text] [Related]
4. Aberrant immune responses in arsenical skin cancers.
Lee CH; Liao WT; Yu HS
Kaohsiung J Med Sci; 2011 Sep; 27(9):396-401. PubMed ID: 21914527
[TBL] [Abstract][Full Text] [Related]
5. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK
Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous manifestations of chronic arsenicism: review of seventeen cases.
Wong SS; Tan KC; Goh CL
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):179-85. PubMed ID: 9486671
[TBL] [Abstract][Full Text] [Related]
7. Arsenic carcinogenesis in the skin.
Yu HS; Liao WT; Chai CY
J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease.
Liao WT; Yu CL; Lan CC; Lee CH; Chang CH; Chang LW; You HL; Yu HS
Carcinogenesis; 2009 Jun; 30(6):1064-72. PubMed ID: 19376847
[TBL] [Abstract][Full Text] [Related]
9. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease.
Matsui M; Nishigori C; Toyokuni S; Takada J; Akaboshi M; Ishikawa M; Imamura S; Miyachi Y
J Invest Dermatol; 1999 Jul; 113(1):26-31. PubMed ID: 10417614
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 promoter -56 and -54bp CpG un-methylation predicts invasive progression in arsenic-induced Bowen's disease.
Liao WT; You HL; Chai CY; Lee CH; Lan CE; Chang SJ; Yu CL; Yu HS
J Dermatol Sci; 2018 Feb; 89(2):191-197. PubMed ID: 29103775
[TBL] [Abstract][Full Text] [Related]
11. Arsenic-related Bowen's disease, palmar keratosis, and skin cancer.
Cöl M; Cöl C; Soran A; Sayli BS; Oztürk S
Environ Health Perspect; 1999 Aug; 107(8):687-9. PubMed ID: 10417369
[TBL] [Abstract][Full Text] [Related]
12. Ureteral tumor with multiple Bowen's disease forty-two years after exposure to arsenic.
Koh E; Kondoh N; Kaihara H; Fujioka H; Kitamura K
Eur Urol; 1989; 16(5):398-400. PubMed ID: 2776813
[TBL] [Abstract][Full Text] [Related]
13. A case of Bowen's disease and small-cell lung carcinoma: long-term consequences of chronic arsenic exposure in Chinese traditional medicine.
Lee L; Bebb G
Environ Health Perspect; 2005 Feb; 113(2):207-10. PubMed ID: 15687059
[TBL] [Abstract][Full Text] [Related]
14. [Bowen's disease with multiple lesions caused by chronic arsenic poisoning].
Giménez H; Agurruza JM; Martínez G; Grasa MP; Carapeto FJ
Actas Dermosifiliogr; 1980; 71(9-10):337-42. PubMed ID: 7223522
[No Abstract] [Full Text] [Related]
15. Arsenic-induced keratoses and Bowen's disease.
Watson K; Creamer D
Clin Exp Dermatol; 2004 Jan; 29(1):46-8. PubMed ID: 14723721
[TBL] [Abstract][Full Text] [Related]
16. Involvement of mtDNA damage elicited by oxidative stress in the arsenical skin cancers.
Lee CH; Wu SB; Hong CH; Chen GS; Wei YH; Yu HS
J Invest Dermatol; 2013 Jul; 133(7):1890-900. PubMed ID: 23370535
[TBL] [Abstract][Full Text] [Related]
17. Small cell lung carcinoma and Bowen's disease 40 years after arsenic ingestion.
Heddle R; Bryant GD
Chest; 1983 Dec; 84(6):776-7. PubMed ID: 6315314
[TBL] [Abstract][Full Text] [Related]
18. Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations.
Hsieh LL; Chen HJ; Hsieh JT; Jee SH; Chen GS; Chen CJ
Cancer Lett; 1994 Oct; 86(1):59-65. PubMed ID: 7954356
[TBL] [Abstract][Full Text] [Related]
19. Arsenical cancer of skin. Histologic study with special reference to Bowen's disease.
Yeh S; How SW; Lin CS
Cancer; 1968 Feb; 21(2):312-39. PubMed ID: 4952508
[No Abstract] [Full Text] [Related]
20. Treatment of arsenical keratosis and Bowen's disease with acitretin.
Yerebakan O; Ermis O; Yilmaz E; Basaran E
Int J Dermatol; 2002 Feb; 41(2):84-7. PubMed ID: 11982642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
